CDKN2A and carcinoma: This different ability of p16 and mRNA to be indicators of regression can be explained by mechanisms that induce silencing of the p16INK4a gene by methylation of its promoter and overexpression of the BMI polycomb-1 gene as already evidenced in carcinomas with p16 negative [42].